Literature DB >> 8673713

Targeted contrast agents in MR imaging.

H Gupta1, R Weissleder.   

Abstract

The use of target specific MR contrast agents can dramatically improve information obtained by MR imaging. This review outlines the various components of target specific MR contrast agents, including various carriers (e.g., monoclonal antibodies, peptides, proteins, polysaccharides, polymers, liposomes, and cells) as well as magnetic labels (e.g., metal ion chelates, free radicals, and iron oxides) and focusses on some promising clinical applications.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8673713

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN： 1064-9689            Impact factor:   2.266


  6 in total

1.  Surface molecular recognition.

Authors:  N S Sampson; M Mrksich; C R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

2.  MRI detection of single particles for cellular imaging.

Authors:  Erik M Shapiro; Stanko Skrtic; Kathryn Sharer; Jonathan M Hill; Cynthia E Dunbar; Alan P Koretsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

Review 3.  Therapeutic response in musculoskeletal soft tissue sarcomas: evaluation by MRI.

Authors:  Xin Wang; Michael A Jacobs; Laura Fayad
Journal:  NMR Biomed       Date:  2011-07       Impact factor: 4.044

4.  Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging.

Authors:  Wenbin Lin; Taeghwan Hyeon; Gregory M Lanza; Miqin Zhang; Thomas J Meade
Journal:  MRS Bull       Date:  2009-06       Impact factor: 6.578

5.  MRI of ICAM-1 upregulation after stroke: the importance of choosing the appropriate target-specific particulate contrast agent.

Authors:  Lisette H Deddens; Geralda A F van Tilborg; Annette van der Toorn; Kajo van der Marel; Leonie E M Paulis; Louis van Bloois; Gert Storm; Gustav J Strijkers; Willem J M Mulder; Helga E de Vries; Rick M Dijkhuizen
Journal:  Mol Imaging Biol       Date:  2013-08       Impact factor: 3.488

Review 6.  Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics.

Authors:  Trung D Tran; Shelton D Caruthers; Michael Hughes; John N Marsh; Tillmann Cyrus; Patrick M Winter; Anne M Neubauer; Samuel A Wickline; Gregory M Lanza
Journal:  Int J Nanomedicine       Date:  2007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.